Mukhtar, Tanzila https://orcid.org/0000-0001-9646-8940
Siebert, Clara-Vita
Wang, Yuejun
Pebworth, Mark-Phillip
White, Matthew L. https://orcid.org/0009-0003-6000-7626
Wu, Tianzhi
Huang, Tan Ieng
Zuo, Guolong https://orcid.org/0000-0003-1214-8849
Ross, Jayden
Baltazar, Jennifer https://orcid.org/0009-0005-0236-0573
Upadhyay, Varun
Shankar, Merut
Zhou, Li
Lombardi-Coronel, Isabel
Mandala, Ishaan
Adam, Manal A.
Wang, Shaohui
Bi, Qiuli
Hoekman, Marco F. M.
Li, Jingjing https://orcid.org/0000-0001-6025-9522
Kriegstein, Arnold R. https://orcid.org/0000-0001-5742-2990
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35NS097305, R35NS097305)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF Early Postdoctoral Mobility Fellowship)
Boehringer Ingelheim
Article History
Received: 9 January 2025
Accepted: 11 June 2025
First Online: 1 July 2025
Competing interests
: A.R.K. is a co-founder, consultant, and member of the Board for Neurona Therapeutics. The other authors declare no conflicting interests.